Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
about
Nanotechnology: Future of OncotherapyProtease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Novel delivery approaches for cancer therapeutics.Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer.Multifunctional Nucleus-targeting Nanoparticles with Ultra-high Gene Transfection Efficiency for In Vivo Gene TherapyRegression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.How nanotechnology can enhance docetaxel therapy.Synthetic low-density lipoprotein (sLDL) selectively delivers paclitaxel to tumor with low systemic toxicity.Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.Trigger responsive polymeric nanocarriers for cancer therapy.Emerging antitumor applications of extracellularly reengineered polymeric nanocarriers.Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics.Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.Ultrasound-responsive nanobubbles contained with peptide-camptothecin conjugates for targeted drug delivery.Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency.Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier.Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs.Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue.Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects.In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene.Photolabile-caged peptide-conjugated liposomes for siRNA delivery.Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.The Current Role of Cell-Penetrating Peptides in Cancer Therapy.Sustained release of methotrexate through liquid-crystalline folate nanoparticles.ACPI Conjugated Gold Nanorods as Nanoplatform for Dual Image Guided Activatable Photodynamic and Photothermal Combined Therapy In Vivo.Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy.Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor
P2860
Q26801067-73298739-E3FE-4833-AE44-D6F257CADB44Q30355600-A5BC5BDB-8585-423A-A563-BE981E6E53EFQ30362001-BF6FAAD0-1CCB-4F73-BFFC-C1ACB382F0A3Q30368171-7DD3AD3D-64C2-45BF-88A3-C539AC2D2DD4Q33563252-83239008-1A31-4CB3-83EB-3FA70F684EB0Q33703111-B6CA88B7-50B1-43E9-9CE7-3E04A6B4CF7DQ35813076-AB273897-1131-4A93-8B5C-9E9409DAF1E0Q37091683-F02D6345-7B8D-4073-8DC1-FDE2178583A5Q37588319-5F924237-CC77-4661-80E2-045D0F0DC3A0Q37735811-78027E80-4654-4D2C-9A4B-80E8A211BCC1Q38495033-D14F6CA5-AE99-4D79-9149-06FDE30DDA51Q38556755-DAF18E42-54F7-4260-925A-3350BA68C239Q38556756-DCE7BDF2-E161-4553-85FA-188F95C8F2DBQ38563910-28B3D135-813B-488B-985D-7CD4512583A4Q38658534-7E385DD5-3074-43A5-845F-4ED55A480468Q38741037-8FBBA5CD-D1F9-4973-8802-7F92300A1062Q38842478-14737108-AD88-459F-8F20-1A0917D7B621Q38852888-A28CF824-335B-4688-A0BE-6597F72F1760Q38886370-005E1714-A008-4535-9997-E2EF9B0D074FQ38927345-F8F370C2-E1A1-4008-AEFB-2EE77BA788F3Q38973330-3C23B041-D91C-4FD1-A666-E959C212DF66Q39103231-B6857F11-1D9B-4098-A0DC-CFDA140AD45DQ41039458-EC03880D-31C6-4836-9B90-CA3C95443321Q42114884-74B8D354-37BA-47FC-8C01-FEAB11515E39Q42335701-4D764686-AF70-4A56-93F8-E64C069C5018Q47440128-E4DD5606-2325-4004-8C2B-58D393317963Q47642768-D529E3DD-F791-483C-B952-27E10736FAEFQ48177108-E38D0B48-7413-4BE1-8756-F20FA43DD9B2Q51008902-2F5B439A-EED8-42EB-8E10-C22A4337F3F2Q51022530-3B834597-8174-4D97-AE7A-7536C992F045Q51155840-637991F0-F6E4-4E70-B4DA-FEFDECE9E061Q52450404-E6171770-DCF8-4C89-8180-4C0C71CE50B6Q52651260-BC3450D7-8B7B-40B3-A0BF-F80FE7741EA9Q53459119-40F2832D-A1F1-4F87-8A09-29671AE30744Q53597574-EC1FB9B9-BD6B-4E8B-A2AB-57E86F932179Q57483726-E0C3773B-B0BC-4002-8B90-679FC655A8DD
P2860
Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chemotherapeutic drug delivery ...... onment-sensitive polypeptides.
@ast
Chemotherapeutic drug delivery ...... onment-sensitive polypeptides.
@en
Chemotherapeutic drug delivery ...... onment-sensitive polypeptides.
@nl
type
label
Chemotherapeutic drug delivery ...... onment-sensitive polypeptides.
@ast
Chemotherapeutic drug delivery ...... onment-sensitive polypeptides.
@en
Chemotherapeutic drug delivery ...... onment-sensitive polypeptides.
@nl
prefLabel
Chemotherapeutic drug delivery ...... onment-sensitive polypeptides.
@ast
Chemotherapeutic drug delivery ...... onment-sensitive polypeptides.
@en
Chemotherapeutic drug delivery ...... onment-sensitive polypeptides.
@nl
P2093
P1433
P1476
Chemotherapeutic drug delivery ...... ronment-sensitive polypeptides
@en
P2093
P304
P356
10.1016/J.BIOMATERIALS.2013.02.014
P50
P577
2013-03-01T00:00:00Z